"Pemphigus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS.
Descriptor ID |
D010392
|
MeSH Number(s) |
C17.800.865.716 C20.111.736
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pemphigus".
Below are MeSH descriptors whose meaning is more specific than "Pemphigus".
This graph shows the total number of publications written about "Pemphigus" by people in this website by year, and whether "Pemphigus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 2 | 0 | 2 |
2009 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 11 | 1 | 12 |
2018 | 15 | 3 | 18 |
2019 | 6 | 1 | 7 |
2020 | 10 | 0 | 10 |
2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Pemphigus" by people in Profiles.
-
A systematic review on efficacy, safety, and treatment-durability of low-dose rituximab for the treatment of Pemphigus: special focus on COVID-19 pandemic concerns. Immunopharmacol Immunotoxicol. 2021 Oct; 43(5):507-518.
-
The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated? J Eur Acad Dermatol Venereol. 2021 Oct; 35(10):e645-e647.
-
Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2. J Eur Acad Dermatol Venereol. 2021 Oct; 35(10):e649-e651.
-
Case Report: Complete and Fast Recovery From Severe COVID-19 in a Pemphigus Patient Treated With Rituximab. Front Immunol. 2021; 12:665522.
-
COVID-19 pandemic and autoimmune bullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation. J Eur Acad Dermatol Venereol. 2021 Jul; 35(7):e418-e421.
-
The risk of COVID-19 in patients with bullous pemphigoid and pemphigus: A population-based cohort study. J Am Acad Dermatol. 2021 07; 85(1):79-87.
-
Topical steroids and topical tacrolimus appear safe regarding the COVID-19 epidemic. Ann Dermatol Venereol. 2021 06; 148(2):122-123.
-
Can rituximab be used in the treatment of pemphigus vulgaris during the COVID-19 pandemic? Dermatol Ther. 2021 Jan; 34(1):e14647.
-
Management of a case of pemphigus foliaceus in a paraplegic man with palliative dermatology principles during COVID-19 pandemic. Dermatol Ther. 2021 Jan; 34(1):e14564.
-
Aggressive course of pemphigus vulgaris following COVID-19 infection. Dermatol Ther. 2020 11; 33(6):e14398.